USA Veterinary Therapeutics Market Report 2018

Table of Contents

1 Report Overview

• 1.1 Definition and Specification
• 1.2 Report Overview
  • 1.2.1 Manufacturers Overview
  • 1.2.2 Regions Overview
  • 1.2.3 Type Overview
  • 1.2.4 Application Overview
• 1.3 Industrial Chain
  • 1.3.1 Veterinary Therapeutics Overall Industrial Chain
  • 1.3.2 Upstream
  • 1.3.3 Downstream
• 1.4 Industry Situation
  • 1.4.1 Industrial Policy
  • 1.4.2 Product Preference
  • 1.4.3 Economic/Political Environment
• 1.5 SWOT Analysis

2 Market Analysis by Types

• 2.1 Overall Market Performance(Volume)
  • 2.1.1 Drugs (Anti-invectives’, Anti-inflammatory, Parasiticides) Market Performance (Volume)
  • 2.1.2 Vaccines (Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines) Market Performance (Volume)
  • 2.1.3 Medicated Feed Additives (Amino Acids, Antibiotics) Market Performance (Volume)
• 2.2 Overall Market Performance(Value)
  • 2.1.1 Drugs (Anti-invectives’, Anti-inflammatory, Parasiticides) Market Performance (Value)
  • 2.1.2 Vaccines (Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines) Market Performance (Value)
  • 2.1.3 Medicated Feed Additives (Amino Acids, Antibiotics) Market Performance (Value)

3 Product Application Market

• 3.1 Overall Market Performance (Volume)
  • 3.1.1 Hospitals Market Performance (Volume)
  • 3.1.2 Veterinary Clinics Market Performance (Volume)
  • 3.1.3 Pharmacies & Drug Stores Market Performance (Volume)

4 Manufacturers Profiles/Analysis

• 4.1 Bayer AG
  • 4.1.1 Bayer AG Profiles
  • 4.1.2 Bayer AG Product Information
  • 4.1.3 Bayer AG Veterinary Therapeutics Business Performance
  • 4.1.4 Bayer AG Veterinary Therapeutics Business Development and Market Status
• 4.2 Boehringer Ingelheim GmbH
  • 4.2.1 Boehringer Ingelheim GmbH Profiles
  • 4.2.2 Boehringer Ingelheim GmbH Product Information
  • 4.2.3 Boehringer Ingelheim GmbH Veterinary Therapeutics Business Performance
  • 4.2.4 Boehringer Ingelheim GmbH Veterinary Therapeutics Business Development and Market Status
• 4.3 Ceva Santé Animale?
  • 4.3.1 Ceva Santé Animale? Profiles
  • 4.3.2 Ceva Santé Animale? Product Information
  • 4.3.3 Ceva Santé Animale? Veterinary Therapeutics Business Performance
  • 4.3.4 Ceva Santé Animale? Veterinary Therapeutics Business Development and Market Status
• 4.4 Dechra Pharmaceuticals PLC
  • 4.4.1 Dechra Pharmaceuticals PLC Profiles
  • 4.4.2 Dechra Pharmaceuticals PLC Product Information
  • 4.4.3 Dechra Pharmaceuticals PLC Veterinary Therapeutics Business Performance
  • 4.4.4 Dechra Pharmaceuticals PLC Veterinary Therapeutics Business Development and Market Status
• 4.5 Eli Lilly and Company (Elanco Animal Health)
  • 4.5.1 Eli Lilly and Company (Elanco Animal Health) Profiles
  • 4.5.2 Eli Lilly and Company (Elanco Animal Health) Product Information
  • 4.5.3 Eli Lilly and Company (Elanco Animal Health) Veterinary Therapeutics Business Performance
  • 4.5.4 Eli Lilly and Company (Elanco Animal Health) Veterinary Therapeutics Business Development and Market Status
• 4.6 Merck Animal Health?
  • 4.6.1 Merck Animal Health? Profiles
  • 4.6.2 Merck Animal Health? Product Information
  • 4.6.3 Merck Animal Health? Veterinary Therapeutics Business Performance
  • 4.6.4 Merck Animal Health? Veterinary Therapeutics Business Development and Market Status
• 4.7 Sanofi (Merial Animal Health)
  • 4.7.1 Sanofi (Merial Animal Health) Profiles
  • 4.7.2 Sanofi (Merial Animal Health) Product Information
  • 4.7.3 Sanofi (Merial Animal Health) Veterinary Therapeutics Business Performance
  • 4.7.4 Sanofi (Merial Animal Health) Veterinary Therapeutics Business Development and Market Status
• 4.8 Virbac
  • 4.8.1 Virbac Profiles
  • 4.8.2 Virbac Product Information
  • 4.8.3 Virbac Veterinary Therapeutics Business Performance
  • 4.8.4 Virbac Veterinary Therapeutics Business Development and Market Status
• 4.9 Vetoquinol S.A.
  • 4.9.1 Vetoquinol S.A. Profiles
  • 4.9.2 Vetoquinol S.A. Product Information
  • 4.9.3 Vetoquinol S.A. Veterinary Therapeutics Business Performance
  • 4.9.4 Vetoquinol S.A. Veterinary Therapeutics Business Development and Market Status
• 4.10 Zoetis, Inc.?
  • 4.10.1 Zoetis, Inc.? Profiles
  • 4.10.2 Zoetis, Inc.? Product Information
  • 4.10.3 Zoetis, Inc.? Veterinary Therapeutics Business Performance
  • 4.10.4 Zoetis, Inc.? Veterinary Therapeutics Business Development and Market Status

5 Market Performance for Manufacturers

• 5.1 USA Veterinary Therapeutics Sales (K Units) and Market Share by Manufacturers 2013-2018
• 5.2 USA Veterinary Therapeutics Revenue (M USD) and Market Share by Manufacturers 2013-2018
• 5.3 USA Veterinary Therapeutics Price (USD/Unit) of Manufacturers 2013-2018
• 5.4 USA Veterinary Therapeutics Gross Margin of Manufacturers 2013-2018
• 5.5 Market Concentration

6 Regions Market Performance for Manufacturers

• 6.1 Northeast Market Performance for Manufacturers
  • 6.1.1 Northeast Veterinary Therapeutics Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.1.2 Northeast Veterinary Therapeutics Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.1.3 Northeast Veterinary Therapeutics Price (USD/Unit) of Manufacturers 2013-2018
  • 6.1.4 Northeast Veterinary Therapeutics Gross Margin of Manufacturers 2013-2018
  • 6.1.5 Market Concentration
• 6.2 Midwest Market Performance for Manufacturers
  • 6.2.1 Midwest Veterinary Therapeutics Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.2.2 Midwest Veterinary Therapeutics Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.2.3 Midwest Veterinary Therapeutics Price (USD/Unit) of Manufacturers 2013-2018
  • 6.2.4 Midwest Veterinary Therapeutics Gross Margin of Manufacturers 2013-2018
  • 6.2.5 Market Concentration
• 6.3 South Market Performance for Manufacturers
  • 6.3.1 South Veterinary Therapeutics Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.3.2 South Veterinary Therapeutics Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.3.3 South Veterinary Therapeutics Price (USD/Unit) of Manufacturers 2013-2018
  • 6.3.4 South Veterinary Therapeutics Gross Margin of Manufacturers 2013-2018
  • 6.3.5 Market Concentration
• 6.4 West Market Performance for Manufacturers
  • 6.4.1 West Veterinary Therapeutics Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.4.2 West Veterinary Therapeutics Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.4.3 West Veterinary Therapeutics Price (USD/Unit) of Manufacturers 2013-2018
  • 6.4.4 West Veterinary Therapeutics Gross Margin of Manufacturers 2013-2018
  • 6.4.5 Market Concentration

7 USA Veterinary Therapeutics Market Performance (Sales Point)

• 7.1 USA Veterinary Therapeutics Sales (K Units) and Market Share by Regions 2013-2018
• 7.2 USA Veterinary Therapeutics Revenue (M USD) and Market Share by Regions 2013-2018
• 7.3 USA Veterinary Therapeutics Price (USD/Unit) by Regions 2013-2018
• 7.4 USA Veterinary Therapeutics Gross Margin by Regions 2013-2018

8 Development Trend for Regions (Sales Point)

• 8.1 USA Veterinary Therapeutics Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.2 Northeast Veterinary Therapeutics Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.3 Midwest Veterinary Therapeutics Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.4 South Veterinary Therapeutics Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.5 West Veterinary Therapeutics Sales and Growth, Sales Value and Growth Rate2013-2018

9 Upstream Source, Technology and Cost

• 9.1 Upstream Source
• 9.2 Technology
• 9.3 Cost

10 Channel Analysis

• 10.1 Market Channel
• 10.2 Distributors

11 Consumer Analysis

• 11.1 Hospitals Industry
• 11.2 Veterinary Clinics Industry
• 11.3 Pharmacies & Drug Stores Industry

12 Market Forecast 2019-2024

• 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
  • 12.1.1 USA Veterinary Therapeutics Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
  • 12.1.2 USA Veterinary Therapeutics Sales (K Units) and Growth Rate 2019-2024
  • 12.1.3 Northeast Veterinary Therapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.4 Midwest Veterinary Therapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.5 South Veterinary Therapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.6 West Veterinary Therapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.7 Veterinary Therapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.8 Veterinary Therapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.9 Veterinary Therapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.10 Veterinary Therapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 12.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
  • 12.3.1 Overall Market Performance
  • 12.3.2 Drugs (Anti-invectives’, Anti-inflammatory, Parasiticides) Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.3.3 Vaccines (Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines) Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.3.4 Medicated Feed Additives (Amino Acids, Antibiotics) Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 12.4 Sales by Application 2019-2024
  • 12.4.1 Overall Market Performance
  • 12.4.2 Hospitals Sales and and Growth Rate 2019-2024
  • 12.4.3 Veterinary Clinics Sales and and Growth Rate 2019-2024
  • 12.4.4 Pharmacies & Drug Stores Sales and and Growth Rate 2019-2024
• 12.5 Price (USD/Unit) and Gross Profit
  • 12.5.1 USA Veterinary Therapeutics Price (USD/Unit) Trend 2019-2024
  • 12.5.2 USA Veterinary Therapeutics Gross Profit Trend 2019-2024

13 Conclusion